ICM | Jotup

ICM and Western New York Energy Enter Agreement to Implement FOT Oil Recovery™ System

Retrieved on:

火曜日, 5月 21, 2024

Engineering, Oil, Gas, Manufacturing, Agriculture, Alternative Energy, Natural Resources, Energy, ICM, Carbon, WNYE, FOT

ICM, Inc. is pleased to announce a strategic collaboration with Western New York Energy, LLC (WNYE) to implement ICM’s cutting-edge FOT Oil Recovery™ system.

Key Points:

ICM, Inc. is pleased to announce a strategic collaboration with Western New York Energy, LLC (WNYE) to implement ICM’s cutting-edge FOT Oil Recovery™ system.
Under the terms of the agreement, ICM will be responsible for engineering, equipment procurement, and installation of its proprietary FOT Oil Recovery™ system at WNYE’s advanced facility in Medina, New York.
FOT Oil Recovery™, a two-step separation system integrated after the distillation process, significantly increases downstream oil recovery by optimizing solids-liquid separation in the whole stillage.
This collaborative approach extends beyond the FOT Oil Recovery™ system and enables ICM to offer better performance guarantees for improved oil recovery.

Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties

Retrieved on:

木曜日, 5月 9, 2024

Partnership, Idealized cognitive model, ICM, Therapy, GSK, Patient, Endometrial cancer, Inflammation, SAN, Pharmaceutical industry

“We believe this amended agreement with Sagard further validates the commercial potential of Anaptys-discovered Jemperli and brings significant non-dilutive funding to Anaptys, further strengthening our balance sheet,” said Daniel Faga, president and chief executive officer of Anaptys.

Key Points:

“We believe this amended agreement with Sagard further validates the commercial potential of Anaptys-discovered Jemperli and brings significant non-dilutive funding to Anaptys, further strengthening our balance sheet,” said Daniel Faga, president and chief executive officer of Anaptys.
A $75 million milestone due upon Jemperli achieving the $1 billion in annual global net sales threshold remains not subject to this agreement.
The capped aggregate Jemperli royalties and milestones to be received by Sagard under this amended agreement have been revised.
Goodwin Procter LLP is acting as counsel to Anaptys, and Foley Hoag LLP is acting as counsel to Sagard, in this monetization transaction.

The smarter E AWARD 2024: Finalists Present Pioneering Solutions for a Renewable 24/7 Energy Supply

Retrieved on:

水曜日, 5月 8, 2024

Environment, Technology, Utilities, Other Technology, Alternative Energy, Sustainability, Green Technology, Energy, Batteries, Exhibition, Intelligence, Energy storage, Multimedia, ICM, Messe, Electricity, Solar energy, Renewable energy

Renewable sources of energy have become increasingly profitable in recent years and are now the most economically viable solution for generating electricity.

Key Points:

Renewable sources of energy have become increasingly profitable in recent years and are now the most economically viable solution for generating electricity.
View the full release here: https://www.businesswire.com/news/home/20240508604806/en/
The finalists for The smarter E AWARD 2024 have been announced in the five categories.
(© Solar Promotion GmbH)
Intelligent, innovative, interdisciplinary – as Europe’s largest alliance of exhibitions for the energy industry, The smarter E Europe highlights key topics for a renewable 24/7 energy supply.
These companies are the finalists of The smarter E AWARD 2024.

Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602

Retrieved on:

月曜日, 5月 6, 2024

Can-Fite recently published an article in Andrologia , suggesting that CF602 could potentially offer an alternative to the current drugs on market.

Key Points:

Can-Fite recently published an article in Andrologia , suggesting that CF602 could potentially offer an alternative to the current drugs on market.
A full erectile recovery was achieved following a single dose of CF602 with restored muscle collagen ratio and endothelial cell function.
“This additional European patent for erectile dysfunction adds to our growing IP estate for this high-value indication of the CF602 drug candidate.
The Erectile Dysfunction market is expected to reach approximately $6.6 billion by 2030, according to Market Research Future.

Impact Capital Managers Celebrates the Five Year Anniversary of the Mosaic Fellowship Program with Largest Cohort to Date

Retrieved on:

火曜日, 5月 7, 2024

NEW YORK, May 7, 2024 /PRNewswire/ -- Impact Capital Managers, the leading network of private capital fund managers investing for superior returns and meaningful impact, is proud to announce the fifth Mosaic Fellowship cohort of 25 graduate students.

Key Points:

NEW YORK, May 7, 2024 /PRNewswire/ -- Impact Capital Managers, the leading network of private capital fund managers investing for superior returns and meaningful impact, is proud to announce the fifth Mosaic Fellowship cohort of 25 graduate students.
The Fellowship is a highly competitive summer program placing top-performing graduate students at ICM member funds, with the objective of advancing traditionally underrepresented talent.
The 25 winners , selected from an applicant pool of over 350 applicants, represents the largest cohort to date.
"My participation in the Mosaic Fellowship has truly come full circle," said Jessica Singh, former Mosaic Fellow and current Associate at Ecosystem Integrity Fund (EIF).

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Worth $26.4 billion | MarketsandMarkets™

Retrieved on:

木曜日, 5月 2, 2024

Based on the North America region, the cardiac monitoring & cardiac rhythm management devices Market is divided into US and Canada.

Key Points:

Based on the North America region, the cardiac monitoring & cardiac rhythm management devices Market is divided into US and Canada.
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Dynamics:
Key Market Players of Cardiac Monitoring & Cardiac Rhythm Management Devices Industry:
The major players in the cardiac monitoring & cardiac rhythm management devices Market are Abbott Laboratories (US), Medtronic (Ireland), Boston Scientific Corporation (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation.
{deal size USD 12.5 billion}
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Key Benefits of Buying the Report:
This report studies the cardiac monitoring & cardiac rhythm management devices market based on Type, Application, Procedure, End User, and Region.
Market Penetration: Comprehensive information on cardiac monitoring & cardiac rhythm management devices Market products offered by the top 25 players in the market.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Worth $26.4 billion | MarketsandMarkets™

Retrieved on:

木曜日, 5月 2, 2024

Based on the North America region, the cardiac monitoring & cardiac rhythm management devices Market is divided into US and Canada.

Key Points:

Based on the North America region, the cardiac monitoring & cardiac rhythm management devices Market is divided into US and Canada.
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Dynamics:
Key Market Players of Cardiac Monitoring & Cardiac Rhythm Management Devices Industry:
The major players in the cardiac monitoring & cardiac rhythm management devices Market are Abbott Laboratories (US), Medtronic (Ireland), Boston Scientific Corporation (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation.
{deal size USD 12.5 billion}
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Key Benefits of Buying the Report:
This report studies the cardiac monitoring & cardiac rhythm management devices market based on Type, Application, Procedure, End User, and Region.
Market Penetration: Comprehensive information on cardiac monitoring & cardiac rhythm management devices Market products offered by the top 25 players in the market.

Majority of U.S. employees say incentive-based pay motivates them at work; lack of trust can have adverse effect

Retrieved on:

水曜日, 4月 24, 2024

Blog, Nature, Motivation, GTM, Communication, Research, Enablement, ICM, Job satisfaction, Trust, Organization, SAN, Ageing

SAN FRANCISCO, April 24, 2024 /PRNewswire/ -- CaptivateIQ, a leading incentive compensation management (ICM) solution, today unveiled the results of its Compensation & Motivation Pulse Survey, which explores how commission-based pay impacts employee motivation and performance.

Key Points:

The research found:
Commissions and bonuses inspire employees to do better work and remain satisfied in their roles.
57% of respondents say working for commissions or bonuses motivates them to do a better job at work, and over half (52%) say it motivates them to hit their goals.
Furthermore, 44% of respondents say it improves job satisfaction and 43% say it makes them feel more engaged at work.
Digging deeper into the survey, we found that lack of trust is a major detractor in the effectiveness of incentive compensation programs."

GEP'S AI-DRIVEN PROCUREMENT & SUPPLY CHAIN SOFTWARE GOES LIVE IN TOPSOE, A GLOBAL LEADER IN CARBON EMISSION REDUCTION TECHNOLOGIES, HELPING TO TRANSFORM PROCUREMENT AND DRIVE NEW VALUE

Retrieved on:

木曜日, 4月 18, 2024

Climate change, ICM, GEP

Headquartered in Denmark and founded in 1940, Topsoe is a leading global provider of technologies and solutions to produce e-fuels, renewable fuels, and low-carbon fuels and chemicals.

Key Points:

Headquartered in Denmark and founded in 1940, Topsoe is a leading global provider of technologies and solutions to produce e-fuels, renewable fuels, and low-carbon fuels and chemicals.
Topsoe is using GEP SOFTWARE to help transform its entire procurement process, encompassing sourcing and contract management, spend analytics, and supplier management.
GEP SOFTWARE encompasses GEP SMART ™, named the world's best procurement software for the second year in a row, GEP NEXXE ™, the next-generation cloud-native supply chain unified platform, and GEP GREEN ™ to measure and advance sustainability.
GEP SOFTWARE is powered by GEP QUANTUM , the industry's leading AI-first, low-code platform.

GEP'S AI-DRIVEN PROCUREMENT & SUPPLY CHAIN SOFTWARE GOES LIVE IN TOPSOE, A GLOBAL LEADER IN CARBON EMISSION REDUCTION TECHNOLOGIES, HELPING TO TRANSFORM PROCUREMENT AND DRIVE NEW VALUE

Retrieved on:

木曜日, 4月 18, 2024

Climate change, ICM, GEP

Headquartered in Denmark and founded in 1940, Topsoe is a leading global provider of technologies and solutions to produce e-fuels, renewable fuels, and low-carbon fuels and chemicals.

Key Points:

Headquartered in Denmark and founded in 1940, Topsoe is a leading global provider of technologies and solutions to produce e-fuels, renewable fuels, and low-carbon fuels and chemicals.
Topsoe is using GEP SOFTWARE to help transform its entire procurement process, encompassing sourcing and contract management, spend analytics, and supplier management.
GEP SOFTWARE encompasses GEP SMART™ , named the world's best procurement software for the second year in a row, GEP NEXXE™ , the next-generation cloud-native supply chain unified platform, and GEP GREEN™ to measure and advance sustainability.
GEP SOFTWARE is powered by GEP QUANTUM , the industry's leading AI-first, low-code platform.